Vanda Pharmaceuticals Inc. (VNDA) Stock Grade

About Vanda Pharmaceuticals Inc.'s fundamentals

Vanda Pharmaceuticals is a small-cap biotech company with a market capitalization of $310.9 million that generated 8.7% year-over-year revenue growth. However, the company is currently unprofitable, operating with a negative net margin of -102.0% and reporting a net loss in its latest annual statement, which means expenses significantly exceed revenues. The company does not pay a dividend and lacks standard profitability metrics like P/E ratio and return on equity due to its loss-making status.